AzTrials
AzTrials

Robot for Endoscopic Neurosurgical InterventionsRENINCT06311266

Robotic Endoscopic Neurosurgical Interventions

A study testing Robotic endoscopic neurosurgical intervention in people with Robot for Endoscopic Neurosurgical Interventions, run by Medical University of Graz at 1 site in Austria.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Endoscopic operations have become increasingly important in the field of neurosurgery over the past decade and require a high degree of precision. Current methods for setting the planned trajectory only offer limited precision due to the manual control, which can lead to complications. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Robotic endoscopic neurosurgical intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteAustria
Study dates
23 Sep 2024to May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Written informed consent to participate in the present study
  • Procedure-related patient insurance
  • Age 18-80 years
  • Diagnosis indicating a ventriculostomy
  • Diagnosis of an endo- or suprasellar lesion with indication for transsphenoidal surgery
  • MRI and CT scanner compatible

Who cannot join

  • Pregnancy, breast feeding
  • Patients not able to reason
  • Age <18 or >80 years
  • Claustrophobia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alexander SG Micko, MD, PhD contact

+4331638581257

alexander.micko@medunigraz.at

Austria1 site, 1 recruiting
  • Medical University of Graz

    Graz, Styria, 8036

    Alexander SG Micko, MD, PhD, +4331638581257, alexander.micko@medunigraz.at

    Recruiting

Other trials in Austria

About this study

Official title: Intraoperative Application of a Robot for Endoscopic Neurosurgical Interventions: A Prospective Study

Endoscopic operations have become increasingly important in the field of neurosurgery over the past decade and require a high degree of precision. Current methods for setting the planned trajectory only offer limited precision due to the manual control, which can lead to complications.

The EndoGuide robot is a modular positioning device for controlling endoscopic instruments, which can use radiological data from neuronavigation to align the trajectory in real time with an accuracy of <0.1mm.

Read more

The previous model of the robot is currently approved for interventional radiology and positioning of electrodes and catheters in the field of neurosurgery and is now to be tested in endoscopic neurosurgery.

The investigators therefore expect not only an increase in the accuracy of endoscopic interventions, but also a reduction in morbidity.

Read the detailed description

Endoscopic procedures, as part of a transnasal pituitary adenoma resection (intervention through the nose to the base of the skull to remove tumors) or ventriculostomy (punctiform opening of a brain chamber to create a bypass circuit for the cerebrospinal fluid), are among the most frequent neurosurgical interventions performed worldwide. The endoscope (ancient Greek: "observe inside") is used for the precise examination of cavities in the context of these minimally invasive interventions. It consists of a rigid tube (diameter approx. 4mm) which transmits the image information of the object or room to be examined through a lens system inside the endoscope shaft to the eyepiece. The light required for the procedure is transmitted from the light source to the tip of the endoscope via the connected light guide, also inside the shaft, through fiber optic bundles.

During neurosurgical interventions, the endoscope is usually guided manually by a second operator. The problem with this manual guidance is the constantly necessary implementation of minimal corrective movements or clouding of the lens due to tissue contact. In case of long lasting interventions, there are also signs of fatigue which lead to unwanted movements of the endoscope. Due to the resulting limited precision and trauma to surrounding tissues, complications and inconclusive results can occur.

In the last 10 years, different surgical devices have been developed to increase procedural accuracy in the field of neurosurgery. For instance, a group presented an automated approach with redundant navigation for minimal invasive extended transsphenoidal skull base surgery successfully performed on cadaveric heads. Furthermore, an assistance system for extended endoscope transsphenoidal skull base surgery has been developed which allowed the simultaneous use of two instruments under endoscopic view. Another approach was to use a force controlled robotic system on bone specimen to increase accuracy for bone milling.

In cooperation with two industrial partners, the COMET Center ACMIT (Austrian Center for Medical Innovation and Technology) developed the MicroMate guidance device that also forms the base for the Stealth AutoGuide system from Medtronic plc. MicroMate is a modular guidance system for surgical invasive tools which provides a precise, submillimetric (<0.1 mm) trajectory alignment according to the predefined navigation data. The setup is based on the iSYS1 robot system, also developed by ACMIT, and on input gained in the course of a clinical trial that has been conducted at the Department of Neurosurgery, Medical University of Vienna 4-10. Notably, none of the two setups mentioned above does impinge on the surgical procedure by itself, nor does it advance any object into the patient. The neurosurgeon remains in control of the instruments during the whole procedure.

The robot used in this study (EndoGuide v2 by ACMIT Gmbh) uses exactly the same mechanical and electronic components as the MicroMate/Stealth AutoGuide system. The only difference between the two CE/FDA certified robots and the EndoGuide platform is a firmware extension to provide a tool pivoting function that allows the endoscope to be rotated around any point along the endoscope shaft. The rotation of the endoscope thus gives the user different views of the area to be viewed.

Aim of the Project The aim of the present study is to evaluate the feasibility and clinical value of the EndoGuide robotic guidance device for intraoperative trajectory alignment in endoscopic neurosurgical procedures (transnasal transphenoidal surgery; ventriculostomy) as compared to the standard freehand method.

With the intraoperative application of the robot the investigators expect:

  • an increase in the accuracy of endoscopic interventions and thus a reduction in intervention- related morbidity,
  • a reduction in trauma and thus also in secondary bleeding in the context of endoscopic interventions.

Rationale Null hypothesis: There is no significant difference between the accuracy of the endoscopic guidance using the robotic guidance device and the accuracy of the manual method. Primary hypothesis: The intraoperative application of the robotic guidance device for precise trajectory alignment significantly increases the accuracy of navigation-guided endoscopic procedure as compared to the standard manual method and thereby reduces procedure-related morbidity.

  1. Hypothesis: The intraoperative application of the robotic guidance device for endoscopic neurosurgical procedures is feasible.
  2. Hypothesis: The intraoperative application of the robotic guidance device increases procedural safety.

Objectives Main Objective: Assessment of Target Error as a Measure for Accuracy The target error (TE) measured in mm, corresponds to the distance between the true (surgically performed) trajectory that has been aligned by the robot and the preoperatively defined trajectory stored on the navigation system.

Using fusion of routine pre- and postoperative radiological images, this distance can be calculated with the navigation system software. Study data will be saved in a password-protected data-base only accessible for study personnel.

Secondary Objectives

Additionally to accuracy, the investigators will test for the following measures:

  • Rate of procedure-related adverse effects (e.g. hemorrhages)
  • Total procedure time (time from skin incision to suture) and setup time (time from positioning the patient to skin incision)
Being tested
Robotic endoscopic neurosurgical intervention
Keywords
robotic, neurosurgery, endoscopic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Robotic endoscopic neurosurgical interventionDevice

    Robotic guidance device for intraoperative trajectory alignment in endoscopic neurosurgical procedures

Study groups in NCT06311266
Study groupRoleWhat they receive
roboticActive comparatorIn the robotic group the endoscope will be guided with the EndoGuide robotic system
Receives: Device: Robotic endoscopic neurosurgical intervention
standard freehandActive comparatorIn the standard freehand group the endoscope will be guided freehand throughout the surgery
Receives: Device: Robotic endoscopic neurosurgical intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Target Error (TE)

    Distance in millimeters between the true (surgically performed) trajectory aligned by the robot, and the preoperatively defined trajectory stored on the navigation system.

    Measured: 30 minutes (during procedure)

Secondary outcomes (1)
  1. Adverse Effect

    Rate of procedure-related adverse effects

    Measured: 7 days (through in-patient stay)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2024
  2. Study start23 Sep 2024
  3. Primary completionNov 2025 (estimated)
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Randomised
Intervention model
Parallel groups
Model description
prospective, randomized, single center cohort trial
Masking
Single blind
Who is masked
Participant
Enrolment
19 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06311266
Sponsor's protocol ID
34-424 ex 21/22
Acronym
RENI
Status last verified
Nov 2024
First submitted
29 Mar 2023
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bumm K, Wurm J, Rachinger J, Dannenmann T, Bohr C, Fahlbusch R, Iro H, Nimsky C. An automated robotic approach with redundant navigation for minimal invasive extended transsphenoidal skull base surgery. Minim Invasive Neurosurg. 2005 Jun;48(3):159-64. doi: 10.1055/s-2005-870903.

    PubMed 16015493
  • Nimsky Ch, Rachinger J, Iro H, Fahlbusch R. Adaptation of a hexapod-based robotic system for extended endoscope-assisted transsphenoidal skull base surgery. Minim Invasive Neurosurg. 2004 Feb;47(1):41-6. doi: 10.1055/s-2003-812465.

    PubMed 15100931
  • Federspil PA, Geisthoff UW, Henrich D, Plinkert PK. Development of the first force-controlled robot for otoneurosurgery. Laryngoscope. 2003 Mar;113(3):465-71. doi: 10.1097/00005537-200303000-00014.

    PubMed 12616198
  • Fichtinger G, Fiene JP, Kennedy CW, Kronreif G, Iordachita I, Song DY, Burdette EC, Kazanzides P. Robotic assistance for ultrasound-guided prostate brachytherapy. Med Image Anal. 2008 Oct;12(5):535-45. doi: 10.1016/j.media.2008.06.002. Epub 2008 Jun 18.

    PubMed 18650122
  • Korb W, Kornfeld M, Birkfellner W, Boesecke R, Figl M, Fuerst M, Kettenbach J, Vogler A, Hassfeld S, Kornreif G. Risk analysis and safety assessment in surgical robotics: a case study on a biopsy robot. Minim Invasive Ther Allied Technol. 2005;14(1):23-31. doi: 10.1080/13645700510010827.

    PubMed 16754150
  • Schulze F, Buhler K, Neubauer A, Kanitsar A, Holton L, Wolfsberger S. Intra-operative virtual endoscopy for image guided endonasal transsphenoidal pituitary surgery. Int J Comput Assist Radiol Surg. 2010 Mar;5(2):143-54. doi: 10.1007/s11548-009-0397-8. Epub 2009 Sep 4.

    PubMed 20033497
  • Fitzpatrick JM. The role of registration in accurate surgical guidance. Proc Inst Mech Eng H. 2010;224(5):607-22. doi: 10.1243/09544119JEIM589.

    PubMed 20718266
  • Martinez-Moreno M, Widhalm G, Mert A, Kiesel B, Bukaty A, Furtner J, Reinprecht A, Knosp E, Wolfsberger S. A novel protocol of continuous navigation guidance for endoscopic third ventriculostomy. Neurosurgery. 2014 Dec;10 Suppl 4:514-23; discussion 523-4. doi: 10.1227/NEU.0000000000000518.

    PubMed 25121792

Questions about this trial

What is this clinical trial studying?

A study testing Robotic endoscopic neurosurgical intervention in people with Robot for Endoscopic Neurosurgical Interventions, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alexander SG Micko, MD, PhD (+4331638581257, alexander.micko@medunigraz.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Target Error (TE) (time frame: 30 minutes (during procedure)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06311266, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in